Rowe Jeffrey M 4/A
4/A · Zomedica Corp. · Filed Mar 27, 2025
Insider Transaction Report
Form 4/AAmended
Rowe Jeffrey M
Director
Transactions
- Purchase
Common Stock, without par value
2025-03-17$0.07/sh+68,000$4,556→ 1,608,127 total(indirect: By Trust) - Purchase
Common Stock, without par value
2025-03-17$0.07/sh+34,725$2,465→ 2,378,485 total(indirect: By Trust) - Purchase
Common Stock, without par value
2025-03-17$0.06/sh+500,000$32,000→ 1,439,480 total(indirect: By Trust) - Purchase
Common Stock, without par value
2025-03-17$0.07/sh+100,647$7,045→ 1,540,127 total(indirect: By Trust) - Purchase
Common Stock, without par value
2025-03-17$0.07/sh+731,368$49,733→ 2,399,495 total(indirect: By Trust) - Purchase
Common Stock, without par value
2025-03-17$0.07/sh+4,265$299→ 2,343,760 total(indirect: By Trust)
Holdings
- 11,301,000(indirect: *)
Common Stock, without par value
Footnotes (2)
- [F1]Form 4 is being amended to correct the total number of shares held by the Jeffrey M. Rowe Living Trust. The original Form 4 reported that Mr. Rowe held 275,000 shares in his individual capacity, however, these shares are held by the Jeffrey M. Rowe Living Trust.
- [F2]11,120,000 held by Rowe Family GST and 181,000 held by IRA